期刊文献+

冠心病患者及介入治疗对CD41水平的影响 被引量:1

CD41 level in patients with coronary artery disease and the influence of PCI
下载PDF
导出
摘要 目的研究冠心病患者的CD41水平,以及经皮冠脉介入治疗(PCI)术对CD41水平的影响。方法测定行PCI术者(235例)及仅行冠状动脉造影(CAG)的患者(121例)手术前及手术后2h的CD41水平。结果术前冠心病患者的CD41水平明显高于非冠心病者(P<0.05)。而在仅行CAG的患者术前与术后CD41水平无明显变化(P>0.05),CD41水平在PCI术后2h高于术前(P<0.05)。结论冠心病患者的血小板活性高于非冠心病者,PCI术可促进血小板激活。 Objective To study CD41 level in patients with coronary artery disease((~AD) and the lnlluence o1 per- cutaneous coronary intervention(PCI). Methods The present study enrolled 235 patients undergoing PCI (PCI group) and 121 patients only undergoing coronary angiography (CAG group). The level of CD41 was detected by flow cytometry. Results The level of CD41 in patients with CAD was significantly higher than that in cases without CAD ( P 〈 0. 05 ). The level of CD41 2 hours after the operation in PCI group was higher than that before PCI ( P 〈 0.05 ). Conclusions The activity of platelet is increased in patients with CAD. Platelet might be activated by PCI.
作者 吕磊 罗义
出处 《实用老年医学》 CAS 2012年第4期312-313,共2页 Practical Geriatrics
基金 广东省卫生厅科技项目(B2003123)
关键词 冠心病 经皮冠状动脉介入治疗 CD41 coronary artery disease percutaneous coronary intervention CD41
  • 相关文献

参考文献5

二级参考文献15

  • 1田乃亮,陈绍良,马玉玲,刘志忠,段宝祥.血清E-选择素和血清C-反应蛋白在急性冠状动脉综合征患者中的变化及意义[J].临床心血管病杂志,2005,21(6):328-329. 被引量:4
  • 2李俊勇,齐晓勇,李英肖,孙智敏.冠心病患者支架术后再狭窄的多因素回归分析[J].中国综合临床,2005,21(12):1070-1072. 被引量:15
  • 3[3]Ray MJ,Walters DL,Bett JN,et al.Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab.Int J Cardiol,2005,101 (2):249-255.
  • 4[4]Mitsios JV,Papathanasiou AI,Elisaf M,et al.The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.Platelets,2005,16 (5):287-92.
  • 5[5]Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance.J Am Coll Cardiol,2006,47(1):27-33.
  • 6MONDORO T H, WALL C D, WHITE M M, et al.Selective induction of a glycoprotein Ⅲ a ligand-indueed binding site by fibrinogen and yon Willebrand factor[J]. Blood, 1996,88:3824-3830.
  • 7MCCOLLAM P L, FOSTER D A, RIESMEYER J S,et al. Cost and effectiveness of glycoprotein Ⅱ b/Ⅲ a-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention[J]. Am J Health Syst Pharm, 2003,60: 1251-1256.
  • 8CHENG D K, JACKEVICIUS C A, SEIDELIN P, et al. Safety of glycoprotein Ⅱ b/Ⅲ a inhibitors in urgent or emergency coronary artery bypass graft surgery[J]. Can J Cardiol, 2004,20:223-228.
  • 9DU CLOS T W, MARNELL L,ZLOCK L R, et al.Analysis of the binding of c-reactive protein to chromatin subunits[J]. J Immunol, 1991, 146: 1220-1225.
  • 10ANZAI T, YOSHIKAWA T, SHIRAKI H, et al. Creactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction[J]. Circulation, 1997, 96: 778- 784.

共引文献3

同被引文献20

  • 1胡志雄,刘湘林,周杨,孙明.载脂蛋白H的新进展及与心脑血管的关系[J].中国医师杂志,2004,6(S1):340-342. 被引量:8
  • 2苗阳,雷燕,高铸烨.急性冠脉综合征病理生理研究概况[J].实用心脑肺血管病杂志,2006,14(1):81-83. 被引量:5
  • 3Lee YW,Kim HJ,Cho YH. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome[J].{H}Clinica Chimica Acta,2007,(1-2):24-27.
  • 4Antoniades C,Bakogiannis C,Tousuulis D. The CD40/CD40 ligand system:linking inflammation with Atherothrombosis[J].JAm Coil Cardiol,2009,(08):669-677.
  • 5M(a)ilarstig A,Lindahl B,Wallentin L. Soluble CD40L levels are regulated by thepolymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome[J].{H}Arteriosclerosis Thrombosis and Vasoular Biology,2006,(07):1667-1673.
  • 6Garlichs CD,Eskafi S,Raaz D. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets[J].{H}HEART,2001,(06):649-655.
  • 7Henn V,Slupsky JR,GrafeM. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells[J].Natrue,1998.159-594.
  • 8Mach F,Sch(o)nbeck U,Sukhova GK. Functional CD40 ligand is expressed on human vascular endothdial cells,smooth muscle cells,and macrophages:implications for CD40-CD40 ligand signaling in atherosclerosis[J].{H}Proceedings of the National Academy of Sciences(USA),1997,(05):1931-1936.
  • 9Graf D,Mullar S,KorthauerU. A soluble form of TRAP(CD40 ligand)is rapidly released afterT cell activation[J].{H}European Journal of Immunology,1995.1749-1754.
  • 10Henn V,Steinbch S,Buchnera k. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed Cl40[J].{H}Blood,2001,(04):1047-1054.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部